These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38061314)

  • 1. Trust in provider and stigma during second-trimester abortion.
    Chesnokova AE; Nagendra D; Dixit E; McAllister A; Schachter A; Schreiber CA; Roe AH; Sonalkar S
    Sex Reprod Healthc; 2024 Mar; 39():100932. PubMed ID: 38061314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized pilot evaluation of individual-level abortion stigma resulting from Pennsylvania mandated abortion counseling.
    Sonalkar S; Gurney EP; McAllister A; Schreiber CA
    Contraception; 2017 Oct; 96(4):227-232. PubMed ID: 28687178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a narrative intervention on individual-level abortion stigma: a randomised controlled trial.
    Sackeim MG; Lee SY; Newton S; Lauderdale D; Gilliam M
    BMJ Sex Reprod Health; 2022 Jan; 48(1):47-53. PubMed ID: 34108187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abortion after diagnosis of fetal anomaly: Psychometric properties of a German version of the individual level abortion stigma scale.
    Hanschmidt F; Nagl M; Klingner J; Stepan H; Kersting A
    PLoS One; 2018; 13(6):e0197986. PubMed ID: 29894474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of individual-level abortion stigma among women seeking elective abortion in Nigeria.
    Oginni A; Ahmadu SK; Okwesa N; Adejo I; Shekerau H
    Int J Womens Health; 2018; 10():361-366. PubMed ID: 30034257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administered versus provider-administered medical abortion.
    Gambir K; Kim C; Necastro KA; Ganatra B; Ngo TD
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013181. PubMed ID: 32150279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring provider preference and provision of abortion methods and stigma: Secondary analysis of a United Kingdom provider survey.
    Footman K; Bright S; Kavanagh J; Parnham E; Bury L; Hoggart L
    Perspect Sex Reprod Health; 2024 Mar; 56(1):50-59. PubMed ID: 38456347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
    Andersson IM; Benson L; Christensson K; Gemzell-Danielsson K
    Hum Reprod; 2016 Jan; 31(1):67-74. PubMed ID: 26573530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Financial and Social Burdens Experienced by Patients Traveling for Abortion Care.
    Addante AN; Paul R; Dorsey M; McNicholas C; Madden T
    Womens Health Issues; 2021; 31(5):426-431. PubMed ID: 34266708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confronting the challenge of unsafe second-trimester abortion.
    Harris LH; Grossman D
    Int J Gynaecol Obstet; 2011 Oct; 115(1):77-9. PubMed ID: 21820115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can mid-level providers manage medical abortion after 12 weeks' gestation as safely and effectively as physicians? A non-inferiority, randomized controlled trial in Addis Ababa, Ethiopia.
    Kapp N; Dijkerman S; Getachew A; Eckersberger E; Pearson E; Abubeker FA; Birara M
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1268-1276. PubMed ID: 38282483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Story Circles and abortion stigma in Mexico: a mixed-methods evaluation of a new intervention for reducing individual level abortion stigma.
    Belfrage M; Ortíz Ramírez O; Sorhaindo A
    Cult Health Sex; 2020 Jan; 22(1):96-111. PubMed ID: 30931806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of stigma and harassment among respondents to the 2019 Canadian abortion provider survey.
    Ennis M; Renner RM; Olure B; Norman WV; Begun S; Martin L; Harris LH; Kean L; Seewald M; Munro S
    Contraception; 2023 Aug; 124():110083. PubMed ID: 37263373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Just-word beliefs and community-level abortion stigma: An exploratory survey.
    Stowers P; Heck R; Csiszar K; Kaneshiro B
    Contraception; 2023 Jun; 122():109979. PubMed ID: 36804051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abortion barriers and perceptions of gestational age among women seeking abortion care in the latter half of the second trimester.
    Janiak E; Kawachi I; Goldberg A; Gottlieb B
    Contraception; 2014 Apr; 89(4):322-7. PubMed ID: 24332434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Relationships Between Experienced and Anticipated Stigma in Health Care Settings, Patient-Provider Race Concordance, and Trust in Providers Among Women Living with HIV.
    Budhwani H; Yigit I; Ofotokun I; Konkle-Parker DJ; Cohen MH; Wingood GM; Metsch LR; Adimora AA; Taylor TN; Wilson TE; Weiser SD; Kempf MC; Sosanya O; Gange S; Kassaye S; Turan B; Turan JM
    AIDS Patient Care STDS; 2021 Nov; 35(11):441-448. PubMed ID: 34739336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health facilities readiness to provide comprehensive abortion care and factors associated with client satisfaction in Central Oromia Region, Ethiopia: a multilevel modeling approach.
    Gebremariam FA; Habtewold EM; Degife DT; Geneti HB; Gebrekiros DH
    Reprod Health; 2023 May; 20(1):72. PubMed ID: 37170219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Experiences Responding to the Individual Level Abortion Stigma Scale: Methodological Considerations From In-depth Interviews.
    Wollum A; Makleff S; Baum SE
    Front Glob Womens Health; 2021; 2():678101. PubMed ID: 34816229
    [No Abstract]   [Full Text] [Related]  

  • 19. Individual abortion providers' experiences with targeted harassment in the United States.
    McLeod C; Pivarnik K; Flink-Bochacki R
    Contraception; 2022 Mar; 107():42-47. PubMed ID: 34728183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.